{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:21:07Z","timestamp":1784010067042,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56 AG019206"],"award-info":[{"award-number":["R56 AG019206"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12035-021-02451-5","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T03:10:35Z","timestamp":1626059435000},"page":"5112-5126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Accumulation of Endogenous Mutant Huntingtin in Astrocytes Exacerbates Neuropathology of Huntington Disease in Mice"],"prefix":"10.1007","volume":"58","author":[{"given":"Liang","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-8838","authenticated-orcid":false,"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"issue":"1","key":"2451_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4(1):49\u201360. https:\/\/doi.org\/10.1038\/nrn1007","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2451_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","volume":"71","author":"S Saxena","year":"2011","unstructured":"Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71(1):35\u201348. https:\/\/doi.org\/10.1016\/j.neuron.2011.06.031","journal-title":"Neuron"},{"issue":"1","key":"2451_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman MY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29(1):15\u201332. https:\/\/doi.org\/10.1016\/s0896-6273(01)00177-5","journal-title":"Neuron"},{"issue":"6968","key":"2451_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968):895\u2013899. https:\/\/doi.org\/10.1038\/nature02263","journal-title":"Nature"},{"key":"2451_CR5","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/ncomms6659","volume":"5","author":"D Vilchez","year":"2014","unstructured":"Vilchez D, Saez I, Dillin A (2014) The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5:5659. https:\/\/doi.org\/10.1038\/ncomms6659","journal-title":"Nat Commun"},{"issue":"6467","key":"2451_CR6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I (2019) Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366(6467):818\u2013822. https:\/\/doi.org\/10.1126\/science.aax3769","journal-title":"Science"},{"key":"2451_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fnins.2017.00185","volume":"11","author":"A Ciechanover","year":"2017","unstructured":"Ciechanover A, Kwon YT (2017) Protein quality control by molecular chaperones in neurodegeneration. Front Neurosci 11:185. https:\/\/doi.org\/10.3389\/fnins.2017.00185","journal-title":"Front Neurosci"},{"issue":"2","key":"2451_CR8","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1038\/35055162","volume":"3","author":"AJ McClellan","year":"2001","unstructured":"McClellan AJ, Frydman J (2001) Molecular chaperones and the art of recognizing a lost cause. Nat Cell Biol 3(2):E51-53. https:\/\/doi.org\/10.1038\/35055162","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2451_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1379\/1466-1268(2003)008<0303:calbtc>2.0.co;2","volume":"8","author":"H McDonough","year":"2003","unstructured":"McDonough H, Patterson C (2003) CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8(4):303\u2013308. https:\/\/doi.org\/10.1379\/1466-1268(2003)008%3c0303:calbtc%3e2.0.co;2","journal-title":"Cell Stress Chaperones"},{"issue":"49","key":"2451_CR10","doi-asserted-by":"publisher","first-page":"32883","DOI":"10.1074\/jbc.273.49.32883","volume":"273","author":"DA Raynes","year":"1998","unstructured":"Raynes DA, Guerriero V Jr (1998) Inhibition of Hsp70 ATPase activity and protein renaturation by a novel Hsp70-binding protein. J Biol Chem 273(49):32883\u201332888. https:\/\/doi.org\/10.1074\/jbc.273.49.32883","journal-title":"J Biol Chem"},{"issue":"21","key":"2451_CR11","doi-asserted-by":"publisher","first-page":"19017","DOI":"10.1074\/jbc.M301109200","volume":"278","author":"CA McLellan","year":"2003","unstructured":"McLellan CA, Raynes DA, Guerriero V (2003) HspBP1, an Hsp70 cochaperone, has two structural domains and is capable of altering the conformation of the Hsp70 ATPase domain. J Biol Chem 278(21):19017\u201319022. https:\/\/doi.org\/10.1074\/jbc.M301109200","journal-title":"J Biol Chem"},{"issue":"9","key":"2451_CR12","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1091\/mbc.e04-04-0293","volume":"15","author":"S Alberti","year":"2004","unstructured":"Alberti S, Bohse K, Arndt V, Schmitz A, Hohfeld J (2004) The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 15(9):4003\u20134010. https:\/\/doi.org\/10.1091\/mbc.e04-04-0293","journal-title":"Mol Biol Cell"},{"issue":"3","key":"2451_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molcel.2004.12.023","volume":"17","author":"Y Shomura","year":"2005","unstructured":"Shomura Y, Dragovic Z, Chang HC, Tzvetkov N, Young JC, Brodsky JL, Guerriero V, Hartl FU et al (2005) Regulation of Hsp70 function by HspBP1: structural analysis reveals an alternate mechanism for Hsp70 nucleotide exchange. Mol Cell 17(3):367\u2013379. https:\/\/doi.org\/10.1016\/j.molcel.2004.12.023","journal-title":"Mol Cell"},{"issue":"37","key":"2451_CR14","doi-asserted-by":"publisher","first-page":"E7803","DOI":"10.1073\/pnas.1710549114","volume":"114","author":"T Zhao","year":"2017","unstructured":"Zhao T, Hong Y, Yin P, Li S, Li XJ (2017) Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins. Proc Natl Acad Sci U S A 114(37):E7803\u2013E7811. https:\/\/doi.org\/10.1073\/pnas.1710549114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"2451_CR15","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin J-Y, Roberts M, Wang C-E, Li X-J, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci 106(52):22480\u201322485. https:\/\/doi.org\/10.1073\/pnas.0911503106","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"2451_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1083\/jcb.200710158","volume":"181","author":"CE Wang","year":"2008","unstructured":"Wang CE, Zhou H, McGuire JR, Cerullo V, Lee B, Li SH, Li XJ (2008) Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J Cell Biol 181(5):803\u2013816. https:\/\/doi.org\/10.1083\/jcb.200710158","journal-title":"J Cell Biol"},{"issue":"7","key":"2451_CR17","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang S, Chang R, Yang H, Zhao T, Hong Y, Kong HE, Sun X, Qin Z et al (2017) CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J Clin Invest 127(7):2719\u20132724. https:\/\/doi.org\/10.1172\/JCI92087","journal-title":"J Clin Invest"},{"issue":"15","key":"2451_CR18","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M et al (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum Mol Genet 19(15):3053\u20133067. https:\/\/doi.org\/10.1093\/hmg\/ddq212","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2451_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.3691","volume":"17","author":"X Tong","year":"2014","unstructured":"Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD, Anderson MA, Mody I et al (2014) Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice. Nat Neurosci 17(5):694\u2013703. https:\/\/doi.org\/10.1038\/nn.3691","journal-title":"Nat Neurosci"},{"issue":"3","key":"2451_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/hmg\/ddy363","volume":"28","author":"TE Wood","year":"2019","unstructured":"Wood TE, Barry J, Yang Z, Cepeda C, Levine MS, Gray M (2019) Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model. Hum Mol Genet 28(3):487\u2013500. https:\/\/doi.org\/10.1093\/hmg\/ddy363","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2451_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","volume":"157","author":"MA Hickey","year":"2008","unstructured":"Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF (2008) Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice. Neuroscience 157(1):280\u2013295. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.041","journal-title":"Neuroscience"},{"issue":"2","key":"2451_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.expneurol.2010.12.017","volume":"228","author":"AC Rising","year":"2011","unstructured":"Rising AC, Xu J, Carlson A, Napoli VV, Denovan-Wright EM, Mandel RJ (2011) Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. Exp Neurol 228(2):173\u2013182. https:\/\/doi.org\/10.1016\/j.expneurol.2010.12.017","journal-title":"Exp Neurol"},{"key":"2451_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fncel.2018.00157","volume":"12","author":"M Jang","year":"2018","unstructured":"Jang M, Lee SE, Cho IH (2018) Adeno-associated viral vector serotype DJ-mediated overexpression of N171\u201382Q-mutant Huntingtin in the striatum of juvenile mice is a new model for Huntington\u2019s disease. Front Cell Neurosci 12:157. https:\/\/doi.org\/10.3389\/fncel.2018.00157","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"2451_CR24","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.celrep.2018.11.019","volume":"25","author":"S Yang","year":"2018","unstructured":"Yang S, Li S, Li XJ (2018) Shortening the half-life of Cas9 maintains its gene editing ability and reduces neuronal toxicity. Cell Rep 25(10):2653-2659.e2653. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.019","journal-title":"Cell Rep"},{"issue":"2","key":"2451_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O et al (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2):440\u2013455. https:\/\/doi.org\/10.1016\/j.cell.2014.09.014","journal-title":"Cell"},{"issue":"1","key":"2451_CR26","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41467-020-16318-1","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Yang S, Jing L, Huang L, Chen L, Zhao X, Yang W, Pan Y et al (2020) Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form. Nat Commun 11(1):2582. https:\/\/doi.org\/10.1038\/s41467-020-16318-1","journal-title":"Nat Commun"},{"issue":"7","key":"2451_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/s0968-0004(02)02125-4","volume":"27","author":"DM Cyr","year":"2002","unstructured":"Cyr DM, Hohfeld J, Patterson C (2002) Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci 27(7):368\u2013375. https:\/\/doi.org\/10.1016\/s0968-0004(02)02125-4","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"2451_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/embo-reports\/kve206","volume":"2","author":"J Hohfeld","year":"2001","unstructured":"Hohfeld J, Cyr DM, Patterson C (2001) From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep 2(10):885\u2013890. https:\/\/doi.org\/10.1093\/embo-reports\/kve206","journal-title":"EMBO Rep"},{"key":"2451_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010814-124332","volume":"55","author":"WB Pratt","year":"2015","unstructured":"Pratt WB, Gestwicki JE, Osawa Y, Lieberman AP (2015) Targeting Hsp90\/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annu Rev Pharmacol Toxicol 55:353\u2013371. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010814-124332","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2451_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnmol.2016.00093","volume":"9","author":"V Joshi","year":"2016","unstructured":"Joshi V, Amanullah A, Upadhyay A, Mishra R, Kumar A, Mishra A (2016) A decade of boon or burden: what has the CHIP ever done for cellular protein quality control mechanism implicated in neurodegeneration and aging? Front Mol Neurosci 9:93. https:\/\/doi.org\/10.3389\/fnmol.2016.00093","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"2451_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171(6):1001\u20131012. https:\/\/doi.org\/10.1083\/jcb.200508072","journal-title":"J Cell Biol"},{"issue":"34","key":"2451_CR32","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","volume":"36","author":"Y Hong","year":"2016","unstructured":"Hong Y, Zhao T, Li XJ, Li S (2016) Mutant Huntingtin impairs BDNF release from astrocytes by disrupting conversion of Rab3a-GTP into Rab3a-GDP. J Neurosci 36(34):8790\u20138801. https:\/\/doi.org\/10.1523\/JNEUROSCI.0168-16.2016","journal-title":"J Neurosci"},{"issue":"4","key":"2451_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/07853890410031948","volume":"36","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli L, Dawson TM (2004) Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med 36(4):315\u2013320. https:\/\/doi.org\/10.1080\/07853890410031948","journal-title":"Ann Med"},{"issue":"12","key":"2451_CR34","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K, Nukina N (2005) Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem 280(12):11635\u201311640. https:\/\/doi.org\/10.1074\/jbc.M412042200","journal-title":"J Biol Chem"},{"issue":"36","key":"2451_CR35","doi-asserted-by":"publisher","first-page":"26714","DOI":"10.1074\/jbc.M601603200","volume":"281","author":"I Al-Ramahi","year":"2006","unstructured":"Al-Ramahi I, Lam YC, Chen HK, de Gouyon B, Zhang M, Perez AM, Branco J, de Haro M et al (2006) CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 281(36):26714\u201326724. https:\/\/doi.org\/10.1074\/jbc.M601603200","journal-title":"J Biol Chem"},{"key":"2451_CR36","doi-asserted-by":"crossref","unstructured":"Howarth JL, Glover CP, Uney JB (2009) HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease. J Neurochem 108(4):945\u2013951","DOI":"10.1111\/j.1471-4159.2008.05847.x"},{"issue":"3","key":"2451_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, Ash P, Shoraka S et al (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117(3):648\u2013658. https:\/\/doi.org\/10.1172\/JCI29715","journal-title":"J Clin Invest"},{"issue":"7","key":"2451_CR38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/hmg\/ddm030","volume":"16","author":"P Kumar","year":"2007","unstructured":"Kumar P, Ambasta RK, Veereshwarayya V, Rosen KM, Kosik KS, Band H, Mestril R, Patterson C et al (2007) CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism. Hum Mol Genet 16(7):848\u2013864. https:\/\/doi.org\/10.1093\/hmg\/ddm030","journal-title":"Hum Mol Genet"},{"issue":"47","key":"2451_CR39","doi-asserted-by":"publisher","first-page":"12163","DOI":"10.1523\/JNEUROSCI.2464-08.2008","volume":"28","author":"S Oddo","year":"2008","unstructured":"Oddo S, Caccamo A, Tseng B, Cheng D, Vasilevko V, Cribbs DH, LaFerla FM (2008) Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J Neurosci 28(47):12163\u201312175. https:\/\/doi.org\/10.1523\/JNEUROSCI.2464-08.2008","journal-title":"J Neurosci"},{"issue":"3","key":"2451_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092098","volume":"9","author":"H Dimant","year":"2014","unstructured":"Dimant H, Zhu L, Kibuuka LN, Fan Z, Hyman BT, McLean PJ (2014) Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics. PLoS One 9(3):e92098. https:\/\/doi.org\/10.1371\/journal.pone.0092098","journal-title":"PLoS One"},{"issue":"Pt 5","key":"2451_CR41","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/brain\/aww028","volume":"139","author":"HJ Chen","year":"2016","unstructured":"Chen HJ, Mitchell JC, Novoselov S, Miller J, Nishimura AL, Scotter EL, Vance CA, Cheetham ME et al (2016) The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain 139(Pt 5):1417\u20131432. https:\/\/doi.org\/10.1093\/brain\/aww028","journal-title":"Brain"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02451-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02451-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02451-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T06:47:10Z","timestamp":1633675630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02451-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02451-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Institutional Animal Use and Care Committee at Emory University and carried out in accordance with the guidelines of Animal Use and Care of the National Institutes of Health (NIH).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}